Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Evidence links 5-HT2A-mGluR2 complex to psychosis

March 11, 2008

Neuroprotective synergy seen with lithium and valproic acid in vitro

March 11, 2008

Anesiva submits sNDA for Zingo for needle insertion pain in adults

March 11, 2008

Recent UCB and Pierre Fabre patents report new compounds for treating neurological disorders

March 11, 2008

ProStrakan receives Swedish marketing authorization for Rapinyl in breakthrough cancer pain

March 11, 2008

New gene involved in ALS identified

March 10, 2008

Recent patents divulge novel analgesic agents

March 10, 2008

Recent patents divulge new antipsychotic agents

March 7, 2008

BTG initiates phase I clinical study of BGC20-0134 for multiple sclerosis

March 6, 2008

Fondation Charcot Stichting to initiate phase I/II trial of Cell Therapeutics' pixantrone

March 6, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...